Back to all updates

about 1 year ago

Tomorrow July 21 Exploring the Virtual Reality Therapeutics (VRx) Pathway

For more info and to register:

Learn about innovating with medical XR from Applied VR President Josh Sackman. AppliedVR's VR-based prescription therapeutic is the first to receive “Breakthrough Device Designation” from the FDA.

Sackman’s talk covers clinical trials and FDA authorization for VR products, and essential topics about AppliedVR's transition from a wellness product to a medical device.

For more info and to register: